PreS1- targeting chimeric antigen receptor T cells diminish HBV infection in liver humanized FRG mice
Virology · 2023-09 · 586 · 23-34
DOI: 10.1016/j.virol.2023.06.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virology, 2023-09. Verfasst von Guilan Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Beijing Normal University, Beijing, China; National Institute of Biological Sciences, Beijing, China. Hauptthemen laut MEDLINE: Hepatitis B virus, Immunotherapy, Adoptive, Hepatitis B. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission, National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Current therapies control but rarely achieve a cure for hepatitis B virus (HBV) infection. Restoration of the HBV-specific immunity by cell-based therapy represents a potential approach for a cure. In this study, we generated HBV specific CAR T cells based on an antibody 2H5-A14 targeting a preS1 region of the HBV large envelope protein. We show that the A14 CAR T cell is capable of killing hepatocytes infected by HBV with high specificity; adoptive transfer of A14 CAR T cells to HBV infected humanized FRG mice resulted in reductions of all serum and intrahepatic virological markers to levels below the detection limit. A14 CAR T cells treatment increased the levels of human IFN-γ, GM-CSF, and IL-8/CXCL-8 in the mice. These results show that A14 CAR T cells may be further developed for curative therapy against HBV infection by eliminating HBV-infected hepatocytes and inducing production of pro-inflammatory and antiviral cytokines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Beijing Normal University, Beijing, China; National Institute of Biological Sciences, Beijing, China.
- National Institute of Biological Sciences, Beijing, China.
- National Institute of Biological Sciences, Beijing, China; Zhongshan School of Medicine, Sun Yet-Sen University, Guangzhou, China.
- National Institute of Biological Sciences, Beijing, China; Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing, 102206, China.
- National Institute of Biological Sciences, Beijing, China; Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing, 102206, China. Electronic address: liwenhui@nibs.ac.cn.
Förderung
- Beijing Municipal Science and Technology Commission
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
- Tsinghua University
Zitieren
APA
Guo, G., He, W., Zhou, Z., Diao, Y., Sui, J., & Li, W. (2023). PreS1- targeting chimeric antigen receptor T cells diminish HBV infection in liver humanized FRG mice. Virology, 586, 23-34. https://doi.org/10.1016/j.virol.2023.06.015
Vancouver
Guo G, He W, Zhou Z, Diao Y, Sui J, Li W. PreS1- targeting chimeric antigen receptor T cells diminish HBV infection in liver humanized FRG mice. Virology. 2023;586:23-34. doi:10.1016/j.virol.2023.06.015
BibTeX
@article{Guo2023,
author = {Guo, Guilan and He, Wenhui and Zhou, Zhongmin and Diao, Yan and Sui, Jianhua and Li, Wenhui},
title = {PreS1- targeting chimeric antigen receptor T cells diminish HBV infection in liver humanized FRG mice},
journal = {Virology},
year = {2023},
volume = {586},
pages = {23--34},
doi = {10.1016/j.virol.2023.06.015}
}
EUVIMED